A phase IIa efficacy and safety trial with intravenous S95011 in primary Sjögren's Syndrome patients. An international, multicentre, randomized, double-blind, placebo-controlled study

Project Details

Short titleA phase IIa efficacy and safety trial with intravenous S95011 in primary Sjögren's Syndrome patients. An international, multicentre, randomized, double-blind, placebo-controlled study
StatusFinished
Effective start/end date1/03/2128/02/22

Funding

  • Servier